Haemonetics (HAE) Total Debt (2010 - 2026)

Haemonetics' Total Debt history runs 17 years deep, the most recent figure standing at $1.2 billion for Q1 2026.

• On a quarterly basis, Total Debt changed 0.02% year-over-year to $1.2 billion in Q1 2026; TTM through Mar 2026 was $1.2 billion, a 0.02% change from a year earlier, with the FY2026 full-year figure at $1.2 billion, changed 0.02% from the prior year.
• Total Debt fell to $1.2 billion in Q1 2026 per HAE's latest filing, from $1.5 billion in the prior quarter.
• Across five years, Total Debt topped out at $1.5 billion in Q4 2025 and bottomed at $762.2 million in Q3 2023.
• The 5-year median for Total Debt is $844.2 million (2022), against an average of $998.8 million.
• Across the five-year window, Total Debt soared 150.89% in 2022 and dropped 6.79% in 2023, its largest moves.
• Year by year, Total Debt stood at $766.8 million in 2022, then increased by 13.54% to $870.6 million in 2023, then jumped by 40.69% to $1.2 billion in 2024, then rose by 24.87% to $1.5 billion in 2025, then dropped by 19.93% to $1.2 billion in 2026.
• Per Business Quant, the three latest HAE Total Debt figures stand at $1.2 billion (Q1 2026), $1.5 billion (Q4 2025), and $1.2 billion (Q3 2025).